Ice Bear Therapeutics

Revolutionizing Insulin Manufacturing

Revolutionizing insulin manufacturing making it faster, cheaper and more sustainable

Our Mission

To bring a revolutionary new advancement to the insulin manufacturing industry. We combine cutting edge mammalian cell line technology with continuous manufacturing bioreactors to dramatically increase the manufacturing output and availability of life saving insulins to the global diabetes community. With an exponential growth in demand and a continuous reduction in insulin availability, the current manufacturing solutions for insulin will be insufficient to meet the future demand which is forecasted to be over 160 Million diabetics in the US alone, and over 500+ million globally. The next evolution in manufacturing insulin has arrived just in time to meet this future need with Ice Bear Therapeutics.
Current manufacturing processes take at least 3 months with large amounts of waste and will not be able to meet the future demand.  Insulin manufacturing has remained resource and cost intensive, until now..

Technology

Advanced mammalian cell lines technology paired with highly efficient continuous manufacturing bioreactors that requires a fraction of resources compared to existing methods.

Past

1901

Present

1960

Future

2030

Products

Biosimilar Lispro

( fast-acting insulin )

Biosimilar Lispro: Our first candidate will be biosimilar Lispro which is a fast-acting insulin taken before meals to provide immediate support for patients with type 1 diabetes. We have forecasted its availability for commercial release in 2030. 

Biosimilar Glargine

( Long-acting insulin )

Our next candidate starting evaluation is biosimilar Glargine, a long-acting insulin. 

Biosimilar Glargine

( Long-acting insulin )

Our next candidate starting evaluation is biosimilar Glargine, a long-acting insulin. 

About Us

Ice Bear Therapeutics is headquartered in Seattle, Washington in the United States of America. We have global manufacturing partners in New Jersey and India. Ice Bear Therapeutics is a registered Social Purpose Company. We believe by lowering our cost of goods and significantly increasing supply, we can meet the demand needs of our customers with reasonable pricing.

Why “Ice Bear”?

Since our children were very young, they have owned stuffed polar bears; and these white, fluffy companions have been a big part of their lives. Our kids have traveled with them, held them in difficult times, and used them as a source of comfort and reassurance. They are, in a very real sense, part of our family. Even as our children and their bears have aged, our kids still love them, and they have given them a nickname: “Icy.” Our family roots are in Germany, and in German, “icy,” in this context, connotes “cute” or “endearing,” and those attributes are universal: Children all over the world find warmth and love in their stuffed bears.
That is why we named our company Ice Bear Therapeutics. We are developing a new process for manufacturing insulin to ensure that the comfort and reassurance that insulin brings to type 1 patients will always be there. We understand the challenges that type 1 diabetes brings for all patients, but children with type 1 face unique physical and emotional challenges. If you’ve witnessed first-hand a child who needs insulin, you will understand why we are so committed to bringing critical innovation to the insulin manufacturing process. Our goal is to ensure that the supply of insulin is dependable, enduring, and life-sustaining. And most important, we want to ensure it’s always there when a child needs it.

Team

A Management & Scientific team committed to solving insulin availability for the future long term diabetic communities.

Christian Pfleger, PhD

Scientist & Pharmacist for 24y

  • pharmaceutical sciences and biotech.
  • Expert in drug development, molecular immunology, and biosimilar manufacturing.
  • Proven track record in leading innovative biotech projects and scaling operations.

Andreas Pfleger, MSc

Pharmacist for 14y Sauter Apotheke

  • 14 years in pharmacy and clinical management.
  • Expertise in drug commercialization, pharmaceutical operations, and managing high-performing teams.
  • Previously led pharmaceutical production and regulatory approvals.

Brian Tagami, BSc

20 Years Enterprise Sales & Marketing

  • Over 20 years of experience in enterprise sales and marketing.
  • Specializes in strategic marketing and biotech sales channels.
  • Extensive background in consumer health and pharmaceutical sales growth.

Steve Hilbert, MBA

18 years Banking & Biotechnology

  • 18 years in banking and biotechnology advisory.
  • Expertise in capital formation, investment strategies, and biotech commercialization.
  • Former Vice President at JP Morgan and Charles Schwab, specializing in biotech investments.

Advisory Board Members

James Hirsch

is an esteemed bestselling author and has raised significant awareness for one of America’s fastest-growing health issues, Diabetes. His book “Cheating Destiny, Living with Diabetes” brings much needed awareness to the issues facing millions of people battling this fast-growing disease.

Irl Hirsch, MD

Dr. Irl Hirsch is one of the foremost experts in Diabetes and has been serving patients for over 30 years. His insights as a clinician who sees patients firsthand will be tremendously valuable as we develop our biosimilar, affordable insulin products.

All of our team members have a personal connection to diabetes and the communities that rely on insulin. We will not fail.

Advisory Board Members

James Hirsch
is an esteemed bestselling author and has raised significant awareness for one of America’s fastest-growing health issues, Diabetes. His book “Cheating Destiny, Living with Diabetes” brings much needed awareness to the issues facing millions of people battling this fast-growing disease.
James Hirsch

is an esteemed bestselling author and has raised significant awareness for one of America’s fastest-growing health issues, Diabetes. His book “Cheating Destiny, Living with Diabetes” brings much needed awareness to the issues facing millions of people battling this fast-growing disease.

James Hirsch

is an esteemed bestselling author and has raised significant awareness for one of America’s fastest-growing health issues, Diabetes. His book “Cheating Destiny, Living with Diabetes” brings much needed awareness to the issues facing millions of people battling this fast-growing disease.

Contact Us

Whether you’re a partner, investor, or simply curious, feel free to contact us for more information.

Location

Ice Bear Therapeutics SPC
701 Fifth Ave, 42nd Floor
Seattle, WA 98104

Email

info@icebeartx.com

Contact Us

Whether you’re a partner, investor, or simply curious, feel free to contact us for more information.

Location

Ice Bear Therapeutics SPC
701 Fifth Ave, 42nd Floor
Seattle, WA 98104

Location

Ice Bear Therapeutics SPC
701 Fifth Ave, 42nd Floor
Seattle, WA 98104

Scroll to Top